BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9507284)

  • 1. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
    Beji M; Louzir B; Ben Rhomdane N; Zouari M; Mtimet B; Daghfous J
    Tunis Med; 1995 May; 73(5):201-3. PubMed ID: 9507284
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of thrombocytopenia caused by rifampicin and pyrazinamide.
    Bansal R; Sharma PK; Sharma A
    Indian J Pharmacol; 2013; 45(4):405-7. PubMed ID: 24014922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
    Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
    Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of drug-resistant tuberculosis.
    Lester W
    Dis Mon; 1971 Apr; ():1-43. PubMed ID: 4327834
    [No Abstract]   [Full Text] [Related]  

  • 9. [Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
    Göpel B; Götte K
    Laryngorhinootologie; 2005 Aug; 84(8):610-9; quiz 621-2. PubMed ID: 16080064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of antituberculosis drugs.
    Girling DJ
    Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920
    [No Abstract]   [Full Text] [Related]  

  • 12. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of thrice-weekly rifampicin for tuberculosis in South-East Asian refugees.
    Mukerjee CM; McKenzie DK
    Aust N Z J Med; 1985 Apr; 15(2):226-9. PubMed ID: 3861165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation].
    Neino Mourtala Mohamed A; Tummino C; Gouitaa M; Chanez P
    Rev Mal Respir; 2013 Nov; 30(9):785-8. PubMed ID: 24267770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampin-induced severe thrombocytopenia in a patient with pulmonary tuberculosis.
    Kindelán JM; Serrano I; Jurado R; Villanueva JL; García-Lázaro M; García-Herola A; Torre Cisneros J
    Ann Pharmacother; 1994 Nov; 28(11):1304-5. PubMed ID: 7849351
    [No Abstract]   [Full Text] [Related]  

  • 18. Antituberculosis agents.
    Goldberger MJ
    Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of tuberculosis for patients with renal impairment.
    Ellard GA
    Nephron; 1993; 64(2):169-81. PubMed ID: 8321347
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.